ahlam1399
09-14-2015, 03:36 AM
Exclusive: Abbott tangles with regulators over Indian cough syrup complaint
NEW DELHI (Reuters) - Drugmaker Abbott Healthcare is challenging an Indian state's accusation that a sample of the company's cough syrup contained excessive levels of codeine, the second multinational to question India's regulatory testing regime in recent months.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49d082f1/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=q1DZTM**ejg:RsHruZgngSs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=q1DZTM**ejg:RsHruZgngSs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/q1DZTM**ejg
NEW DELHI (Reuters) - Drugmaker Abbott Healthcare is challenging an Indian state's accusation that a sample of the company's cough syrup contained excessive levels of codeine, the second multinational to question India's regulatory testing regime in recent months.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49d082f1/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=q1DZTM**ejg:RsHruZgngSs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=q1DZTM**ejg:RsHruZgngSs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=q1DZTM**ejg:RsHruZgngSs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/q1DZTM**ejg